Paul Breaux - Feb 10, 2025 Form 4 Insider Report for CARVANA CO. (CVNA)

Signature
/s/ Paul Breaux
Stock symbol
CVNA
Transactions as of
Feb 10, 2025
Transactions value $
-$10,418,642
Form type
4
Date filed
2/12/2025, 06:12 PM
Previous filing
Feb 4, 2025
Next filing
Mar 4, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVNA Class A Common Stock Options Exercise $13.7K +1.36K +0.89% $10.07 155K Feb 10, 2025 Direct F1
transaction CVNA Class A Common Stock Sale -$368K -1.36K -0.88% $270.08 153K Feb 10, 2025 Direct F1, F2
transaction CVNA Class A Common Stock Options Exercise $389K +38.6K +25.21% $10.07 192K Feb 11, 2025 Direct F1
transaction CVNA Class A Common Stock Sale -$7.71M -28.5K -14.86% $270.34 163K Feb 11, 2025 Direct F1, F3
transaction CVNA Class A Common Stock Sale -$2.74M -10.1K -6.19% $271.15 153K Feb 11, 2025 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVNA Stock Options (Right to Buy) Options Exercise $0 -1.36K -0.49% $0.00 278K Feb 10, 2025 Class A Common Stock 1.36K $10.07 Direct F1, F5
transaction CVNA Stock Options (Right to Buy) Options Exercise $0 -38.6K -13.9% $0.00 239K Feb 11, 2025 Class A Common Stock 38.6K $10.07 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported option exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2023 (the "10b5-1 Plan").
F2 This transaction was executed in multiple trades at prices ranging from $270.00 to $270.12, inclusive. The price reported above reflects the volume weighted average sale price. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
F3 This transaction was executed in multiple trades at prices ranging from $270.00 to $270.99, inclusive. The price reported above reflects the volume weighted average sale price. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
F4 This transaction was executed in multiple trades at prices ranging from $271.00 to $271.39, inclusive. The price reported above reflects the volume weighted average sale price. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
F5 The non-qualified stock options representing the right to purchase for the exercise price Class A Common Stock of the Issuer vested 25% on April 1, 2024 and vest monthly thereafter for the following three years, subject to the Reporting Person's continued service with the Issuer.

Remarks:

Vice President, General Counsel, Secretary, and Chief Compliance Officer